Traditional factors including T stage, N status, histological grade, histological type, ER status, HER2 gene status, and menopausal status were associated with invasive BC patients' 5-DFS (P < 0.05 for all) (Supplementary Table 1). This evidence concerns the gene ERBB2 and breast cancer.